mbxbio.com - MBX Company profit before taxes, interest and amortization

Graphic logo of MBX Biosciences (MBX)

MBX Biosciences Inc (MBX) automates the discovery of peptides for metabolic pathologies through AI modeling. The EBITDA volatility on GURU.Markets captures the development trend, where the 0.00 mark indicates the profit level. Financial potential is based on the procurement of innovative injections by clinics. The current structure is supported by external capital, as commercial products remain in the clinical trial stage.

MBX MBX Corp: Operating profit EBITDA in the range 11/23/2025 - 11/12/2026

Summary analytical data breakdowns for MBX Biosciences (MBX)

- market value and analyst target forecast:
Market Price MBX Corp|MBX - Consensus Target
- issuer market value details:
Market Value MBX Biosciences|MBX - Enterprise Value
- issuer book value statistics:
Book Value per Share MBX Biosciences|MBX - Book Capitalization|Market Value to Book Value Ratio mbxbio.com|MBX - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Capital MBX Biosciences Inc|MBX - Long-Term Debt to Equity|Short-Term Debt to Equity MBX Biosciences, Inc.|MBX - Company Aggregate Debts|Debts to Net Assets MBX Biosciences|MBX - Company Long-Term Debt|Short-Term Debt Volume MBX Biosciences|Quick Liquidity Indicator mbxbio.com
- business earnings and investment ratios data:
MBX - Company Net Income|Future Profit MBX Biosciences Inc|MBX - P/E Multiple|Future Price to Earnings mbxbio.com|MBX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation MBX Biosciences|MBX - Operating profit before deduction of amortization|Earnings per share for the trailing year MBX Biosciences|MBX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months mbxbio.com|MBX - Earnings growth in current year|Consensus forecast of earnings per share growth for next year MBX Biosciences Inc
Summary company analytics:MBX MBX Corp
Manufactured product of MBX Biosciences, Inc.

To assess the stability of MBX Biosciences Inc (MBX), it is essential to track the actual cash flow from operating activities, net of taxes and interest. By analyzing the EBITDA chart, an investor can determine the extent to which the automation of drug synthesis offsets the high costs of clinical medical support, which directly dictates the company's ability to maintain capital without external borrowing.

Competitors of MBX Biosciences Inc (MBX)

Ascendis (ASND) - Profit before interest, taxes and amortization|MDGL: Operating profit before deduction of amortization|corcept.com - Company profit before taxes, interest and amortization|RYTM: Operating profit EBITDA|Akero Therapeutics, Inc. (AKRO) - Operating profit EBITDA|MTSR (Metsera Corp) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization MLTX|Profit before payment of interest, taxes and amortization Crinetics Pharmaceuticals (CRNX)|NAMS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Soleno Therapeutics, Inc. SLNO|Amicus Therapeutics Inc - Profit before payment of interest, taxes and amortization|89bio Corp - Operating profit EBITDA|Operating income before deduction of amortization Agios Corp AGIO|Structure Therapeutics (GPCR) - Profit before payment of interest, taxes and amortization|MDXG - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Rezolute|Operating profit before deduction of amortization Lexicon Pharmaceuticals Inc (LXRX)|Profit before payment of interest, taxes and amortization Altimmune Corp (ALT)|Operating profit before deduction of amortization Aardvark Pharma AARD|Operating profit EBITDA SGMT (Sagimet Biosciences)|bioagelabs.com - Profit before payment of interest, taxes and amortization|BMEA: Operating profit before deduction of amortization|QNCX (Quince Therapeutics) - Operating profit before amortization|GUTS (Fractyl) - Operating profit before deduction of amortization|vTv Therapeutics - Income before deduction of interest, taxes and amortization|ATPC (Agape ATP Corp) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization PLUR|Operating profit EBITDA SYBX|Operating income before deduction of amortization Lipocine Inc|Profit before payment of interest, taxes and amortization Matinas BioPharma Holdings MTNB|sprucebiosciences.com (SPRB) - Profit before interest, taxes and amortization|GLTO - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization carmellrx.com CTCX|LUMO: Operating profit EBITDA|Operating profit before deduction of amortization Organovo Holdings|RDUS (Radius Health) - Operating profit EBITDA